Insilico Medicine begins clinical trial for AI-designed cancer drug ISM3412

Insilico Medicine(“Insilico”), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announces that the…

AI-designed drug shows early promise for lung fibrosis patients in clinical trial

A groundbreaking phase 2a study reveals that rentosertib, an AI-developed TNIK inhibitor, could offer new hope…